13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001839882-25-008942
Total Value
$746.0M
Positions
85
Other Managers
0
Confidential Omitted
No
Holdings (85)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 750,000 | $67.5M | 9.05% |
| 2 | XENON PHARMACEUTICALS INC | XENE | 1,161,237 | $45.5M | 6.10% |
| 3 | APOGEE THERAPEUTICS INC | APGE | 931,728 | $42.2M | 5.66% |
| 4 | ARCELLX INC | ACLX | 425,000 | $32.6M | 4.37% |
| 5 | ALKERMES PLC | ALKS | 1,100,000 | $31.6M | 4.24% |
| 6 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,400,000 | $30.9M | 4.14% |
| 7 | VERONA PHARMA PLC | 925050106 | 660,000 | $30.7M | 4.11% |
| 8 | MADRIGAL PHARMACEUTICALS INC | MDGL | 82,500 | $25.5M | 3.41% |
| 9 | CRINETICS PHARMACEUTICALS IN | CRNX | 460,000 | $23.5M | 3.15% |
| 10 | NUVALENT INC | NUVL | 285,000 | $22.3M | 2.99% |
| 11 | SPYRE THERAPEUTICS INC | SYRE | 824,328 | $19.2M | 2.57% |
| 12 | WAVE LIFE SCIENCES LTD | WVE | 1,500,000 | $18.6M | 2.49% |
| 13 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,095,924 | $18.4M | 2.46% |
| 14 | VERA THERAPEUTICS INC | VERA | 425,000 | $18.0M | 2.41% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 940,083 | $17.7M | 2.37% |
| 16 | MESOBLAST LTD | MEOBF | 838,600 | $16.6M | 2.23% |
| 17 | MERUS N V | N5749R100 | 389,241 | $16.4M | 2.19% |
| 18 | COHERUS BIOSCIENCES INC | 19249HAB9 | 16,625,000 | $16.2M | 2.17% |
| 19 | OMEROS CORP | OMER | 15,525,000 | $14.6M | 1.96% |
| 20 | ESTABLISHMENT LABS HLDGS INC | ESTA | 279,445 | $12.9M | 1.73% |
| 21 | ARVINAS INC | ARVN | 630,000 | $12.1M | 1.62% |
| 22 | KARYOPHARM THERAPEUTICS INC | KPTI | 15,250,000 | $11.9M | 1.59% |
| 23 | INOZYME PHARMA INC | 45790W108 | 3,972,318 | $11.0M | 1.47% |
| 24 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 425,000 | $10.9M | 1.46% |
| 25 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,500,000 | $10.6M | 1.42% |
| 26 | GERON CORP | GERN | 2,250,000 | $8.0M | 1.07% |
| 27 | AMGEN INC | AMGN | 30,000 | $7.8M | 1.05% |
| 28 | REZOLUTE INC | RZLT | 1,575,000 | $7.7M | 1.03% |
| 29 | PROQR THRAPEUTICS N V | N71542109 | 2,825,000 | $7.5M | 1.00% |
| 30 | ORUKA THERAPEUTICS INC | ORKA | 368,698 | $7.1M | 0.96% |
| 31 | AXSOME THERAPEUTICS INC | AXSM | 75,000 | $6.3M | 0.85% |
| 32 | ERASCA INC | ERAS | 2,499,431 | $6.3M | 0.84% |
| 33 | SOLENO THERAPEUTICS INC | SLNO | 130,000 | $5.8M | 0.78% |
| 34 | TRAVERE THERAPEUTICS INC | TVTX | 6,000,000 | $5.7M | 0.77% |
| 35 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 300,000 | $5.6M | 0.76% |
| 36 | BRIDGEBIO PHARMA INC | BBIO | 200,000 | $5.5M | 0.74% |
| 37 | NEUMORA THERAPEUTICS INC. | NMRA | 475,000 | $5.0M | 0.67% |
| 38 | PROTAGONIST THERAPEUTICS INC | PTGX | 130,000 | $5.0M | 0.67% |
| 39 | MINERALYS THERAPEUTICS INC | MLYS | 350,000 | $4.3M | 0.58% |
| 40 | PERSPECTIVE THERAPEUTICS INC | CATX | 1,300,000 | $4.1M | 0.56% |
| 41 | CASSAVA SCIENCES INC | 14817C107 | 1,739,400 | $4.1M | 0.55% |
| 42 | AVALO THERAPEUTICS INC | AVTX | 550,765 | $4.1M | 0.55% |
| 43 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 350,000 | $3.6M | 0.48% |
| 44 | TRAVERE THERAPEUTICS INC | TVTX | 200,000 | $3.5M | 0.47% |
| 45 | INSMED INC | INSM | 50,000 | $3.5M | 0.46% |
| 46 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 237,935 | $3.3M | 0.45% |
| 47 | COMPASS PATHWAYS PLC | CMPS | 850,512 | $3.2M | 0.43% |
| 48 | GALECTIN THERAPEUTICS INC | GALT | 2,492,000 | $3.2M | 0.43% |
| 49 | CULLINAN THERAPEUTICS INC | CGEM | 263,817 | $3.2M | 0.43% |
| 50 | VIRIDIAN THERAPEUTICS INC | VRDN | 159,614 | $3.1M | 0.41% |
| 51 | MIRUM PHARMACEUTICALS INC | MIRM | 70,742 | $2.9M | 0.39% |
| 52 | CG ONCOLOGY INC | CGON | 100,000 | $2.9M | 0.38% |
| 53 | TECTONIC THERAPEUTIC INC | TECX | 58,331 | $2.7M | 0.36% |
| 54 | HELIX ACQUISITION CORP II | HLXC | 250,000 | $2.6M | 0.35% |
| 55 | OAKTREE ACQUISITION CORP III | OACCW | 250,000 | $2.5M | 0.34% |
| 56 | IMMUNOVANT INC | IMVT | 100,000 | $2.5M | 0.33% |
| 57 | AEROVATE THERAPEUTICS INC | 008064107 | 800,000 | $2.1M | 0.28% |
| 58 | VAXCYTE INC | PCVX | 25,000 | $2.0M | 0.27% |
| 59 | NKARTA INC | NKTX | 800,000 | $2.0M | 0.27% |
| 60 | NEXTCURE INC | NXTC | 2,302,598 | $1.8M | 0.24% |
| 61 | ANTERIS TECHNOLOGIES GLOBAL | AVR | 300,000 | $1.7M | 0.22% |
| 62 | KYMERA THERAPEUTICS INC | KYMR | 40,000 | $1.6M | 0.22% |
| 63 | APELLIS PHARMACEUTICALS INC | APLS | 50,000 | $1.6M | 0.21% |
| 64 | RAPT THERAPEUTICS INC | 75382E109 | 1,000,000 | $1.6M | 0.21% |
| 65 | INARI MED INC | 45332Y109 | 25,000 | $1.3M | 0.17% |
| 66 | SAVARA INC | SVRA | 410,586 | $1.3M | 0.17% |
| 67 | ONKURE THERAPEUTICS INC | OKUR | 144,159 | $1.2M | 0.17% |
| 68 | BLACK DIAMOND THERAPEUTICS I | BDTX | 559,163 | $1.2M | 0.16% |
| 69 | CONTEXT THERAPEUTICS INC | CNTX | 1,015,340 | $1.1M | 0.14% |
| 70 | KEZAR LIFE SCIENCES INC | KZR | 142,316 | $956,364 | 0.13% |
| 71 | CLIMB BIO INC | CLYM | 500,000 | $900,000 | 0.12% |
| 72 | RADIOPHARM THERANOSTICS LTD | RDPTF | 156,171 | $684,029 | 0.09% |
| 73 | IMMUNITYBIO INC | IBRX | 250,000 | $640,000 | 0.09% |
| 74 | BIOMEA FUSION INC | BMEA | 150,000 | $582,000 | 0.08% |
| 75 | ZURA BIO LTD | ZURA | 223,335 | $558,338 | 0.07% |
| 76 | SYROS PHARMACEUTICALS INC | 87184Q206 | 1,541,200 | $354,168 | 0.05% |
| 77 | CELLDEX THERAPEUTICS INC NEW | CLDX | 9,992 | $252,498 | 0.03% |
| 78 | ADAGIO MED HLDGS INC | 00534B100 | 213,235 | $223,897 | 0.03% |
| 79 | REPARE THERAPEUTICS INC | 760273102 | 100,000 | $131,000 | 0.02% |
| 80 | OMEROS CORP | OMER | 9,958 | $98,385 | 0.01% |
| 81 | Q32 BIO INC | QTTB | 27,777 | $95,553 | 0.01% |
| 82 | IMMATICS N.V | IMTX | 187,204 | $47,082 | 0.01% |
| 83 | SYROS PHARMACEUTICALS INC | 87184Q206 | 150,000 | $34,470 | 0.00% |
| 84 | SOLENO THERAPEUTICS INC | SLNO | 200 | $8,990 | 0.00% |
| 85 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $2,573 | 0.00% |